AAAAAA

   
Results: 1-18 |
Results: 18
An open letter to the Committee on the Nobel Prize in Medicine
Authors: Abbruzzese, G Agid, Y Albanese, A Alf, C Allen, R Amar, K de Andrade, LA Ang, LC Angelini, C Archer, RL Arunodaya, GR Baltzan, M Baral, K Barnett, H Bergamasco, B Berger, M Bernard, J Bharucha, NE Bhatia, K Blary, N Black, S Bodis-Wollner, I Boyson, SJ Bral-Kulaksizoglu, I Brooks, DJ Brown, JD Burke, RE Calne, DOC Calne, SM Cardoso, F Cardozo-Pelaez, F Chang, YJ Chen, CC Chen, RS Chen, R Chowdhury, A Christie, S Chu, CC Chu, NS Clarida, L Collette, EM Comella, C Conneally, PM Crossman, AR Csanda, E Dalmau, J Dalvi, A De Feijter, A Deecke, L Desai, H De Ybenes, J Dihenia, B Direnfeld, L Dodel, R Donat, J Doudet, D Duane, DD Duff, J Duvoisin, R Eggert, K Elble, RJ Elmer, LW Emre, M Fariello, R Fernendy, HH Findley, LJ Fink, S Freissmuth, M Friedman, JH de la Fuente-Fernandez, R Furtado, S Furukawa, Y Galvez-Jimenez, N Gauthier, S Gawel, MJ Gilman, S Gladstone, RM Goetz, CG Gomori, A Gopinathan, G Gordin, A Gorell, JM Greenamyre, JT Grimes, DA Gurvit, H Guttman, M Guzman, DA Hachinski, V Hanagasi, H Hardy, J Harik, SJ Hassan, MN Hattori, N Hauser, RA Hayashi, H Heller, GL Hobson, D Hochschorner, G Hortnagel, H Horowski, R Howse, DC Huang, CC Huk, II Hurtig, H Hutton, JT Jaffe, ME Jankovic, J Jardine, M Jog, M Johnson, B Kagamihara, Y Karagoz, N Kasper, S Kato, S Kebabian, JW Kertsz, A Khadilkar, SV Kirk, A Kish, S Kitaguchi, T Kofman, OS Koide, R Komori, T Kostyuk, PG Kumar, R Kuo, HC Kurlan, R Kurland, L Kurtuncu, M Lalkaka, JA Lambert, M Landau, W Lang, AE Lassmann, H Lee, CS Lees, AJ Lieberman, A Litvan, I Loeb, C Logan, WJ Lozano, AM Lu, CS Lucy, D Lynch, T Manyam, BV Maraganore, D Marshall, FT Martin, WRW Martin, WE Mathias, C Matsubera, S Mendis, T Menkes, JH Metz, LN Miyazaki, Y Mizuno, Y Mohr, E Moodley, LG Moore, R Morris, JL Muthane, U Nagaraja, D Nair, CPV Narabayashi, H Nomura, Y Norris, JW Obeso, JA O'Brien, C Oertel, W Ohtake, T Okiyama, R Ozdemir, C Pal, PK Panisset, M Paty, DW Paulson, GW Perlmutter, J Pfeiffer, RF Pifl, C Pincus, JH Poewe, W Quinn, N Rajput, AH Rajput, A Ransmayr, G Rascol, O Robinson, R Rocca, WA Roos, RAC Rosenfeld, MR Russell, D Ruth, TJ Ryu, SJ Sachdev, H Safoschnik, G Sahin, H Sanchez-Ramos, J Satishchandra, P Schapira, A",Scheltens,"Schmidley, JW Schnaberth, G Schneider, E Schneider, JS Schutz, W Seeberger, LC Segawa, M Sethi, KD Shah, A Shannon, K Shelton, P Shihabuddin, B Shimizu, T Shinotoh, H Siddique, T Siderowf, A Sieghart, W Simard, A Simmonds, DC Singhal, BS Sluga, E Snow, BJ Soukop, W Sperk, G Spieker, S Steele, JC Stewart, S Stoessl, AJ Subramony, SH Sundaram, M Sung, CY Surya, N Sweet, RD Tabbal, SD Takahashi, H Taniguchi, M Tarsy, D Teravainen, H Tetrud, JW Tolosa, E Tourtellotte, WW Troupin, AS Tsui, JKC Tuite, P Uc, EY Ueki, Y Uitti, R Uyu, C van Hilten, JJ Veerendrakumar, M Veloso, F Viallet, F Voll, C Vrooman, M Wang, X Ward, I Ward, A Waters, C Weng, YH Wenning, GK Williams, BJ Wilson, TW Wolters, EC Wooten, FG Wszolek, Z Yahr, MD Yanagisawa, N Yokochi, F Young, RR Yu, CM Zifko, U
Citation: G. Abbruzzese et al., An open letter to the Committee on the Nobel Prize in Medicine, PARKINS R D, 7(2), 2001, pp. 149-155
Management of psychosis in Parkinson's disease
Authors: Wolters, EC Berendse, HW
Citation: Ec. Wolters et Hw. Berendse, Management of psychosis in Parkinson's disease, CURR OP NEU, 14(4), 2001, pp. 499-504
Imaging of dopamine transporters with [I-123]FP-CIT SPECT does not suggesta significant effect of age on the symptomatic threshold of disease in Parkinson's disease
Authors: Booij, J Bergmans, P Winogrodzka, A Speelman, JD Wolters, EC
Citation: J. Booij et al., Imaging of dopamine transporters with [I-123]FP-CIT SPECT does not suggesta significant effect of age on the symptomatic threshold of disease in Parkinson's disease, SYNAPSE, 39(2), 2001, pp. 101-108
Rigidity decreases resting tremor intensity in Parkinson's disease: A [I-123]beta-CIT SPECT study in early, nonmedicated patients
Authors: Winogrodzka, A Wagenaar, RC Bergmans, P Vellinga, A Booij, J van Royen, EA van Emmerik, REA Stoof, JC Wolters, EC
Citation: A. Winogrodzka et al., Rigidity decreases resting tremor intensity in Parkinson's disease: A [I-123]beta-CIT SPECT study in early, nonmedicated patients, MOVEMENT D, 16(6), 2001, pp. 1033-1040
Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17): PPND family. A longitudinal videotape demonstration
Authors: Wszolek, ZK Kardon, RH Wolters, EC Pfeiffer, RF
Citation: Zk. Wszolek et al., Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17): PPND family. A longitudinal videotape demonstration, MOVEMENT D, 16(4), 2001, pp. 756-760
Loss of olfaction in de novo and treated Parkinson's disease: Possible implications for early diagnosis
Authors: Tissingh, G Berendse, HW Bergmans, P DeWaard, R Drukarch, B Stoof, JC Wolters, EC
Citation: G. Tissingh et al., Loss of olfaction in de novo and treated Parkinson's disease: Possible implications for early diagnosis, MOVEMENT D, 16(1), 2001, pp. 41-46
Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell
Authors: Berendse, HW Booij, J Francot, CMJE Bergmans, PLM Hijman, R Stoof, JC Wolters, EC
Citation: Hw. Berendse et al., Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell, ANN NEUROL, 50(1), 2001, pp. 34-41
The clinical benefit of imaging striatal dopamine transporters with [I-123]FP-CIT SPET in differentiating patients with presynaptic parkinsonism fromthose with other forms of parkinsonism
Authors: Booij, J Speelman, JD Horstink, MWIM Wolters, EC
Citation: J. Booij et al., The clinical benefit of imaging striatal dopamine transporters with [I-123]FP-CIT SPET in differentiating patients with presynaptic parkinsonism fromthose with other forms of parkinsonism, EUR J NUCL, 28(3), 2001, pp. 266-272
[I-123]FP-CIT SPECT is a useful method to monitor the rate of dopaminergicdegeneration in early-stage Parkinson's disease
Authors: Winogrodzka, A Bergmans, P Booij, J van Royen, EA Janssen, AGM Wolters, EC
Citation: A. Winogrodzka et al., [I-123]FP-CIT SPECT is a useful method to monitor the rate of dopaminergicdegeneration in early-stage Parkinson's disease, J NEURAL TR, 108(8-9), 2001, pp. 1011-1019
Motor perseveration is an early sign of Parkinson's disease
Authors: Stoffers, D Berendse, HW Deijen, JB Wolters, EC
Citation: D. Stoffers et al., Motor perseveration is an early sign of Parkinson's disease, NEUROLOGY, 57(11), 2001, pp. 2111-2113
Preclinical (premotor) Parkinson's disease
Authors: Wolters, EC Francot, C Bergmans, P Winogrodzka, A Booij, J Berendse, HW Stoof, JC
Citation: Ec. Wolters et al., Preclinical (premotor) Parkinson's disease, J NEUROL, 247, 2000, pp. 103-109
L-Glutamate, L-arginine and L-citrulline levels in cerebrospinal fluid of Parkinson's disease, multiple system atrophy, and Alzheimer's disease patients
Authors: Kuiper, MA Teerlink, T Visser, JJ Bergmans, PLM Scheltens, P Wolters, EC
Citation: Ma. Kuiper et al., L-Glutamate, L-arginine and L-citrulline levels in cerebrospinal fluid of Parkinson's disease, multiple system atrophy, and Alzheimer's disease patients, J NEURAL TR, 107(2), 2000, pp. 183-189
Dopamine D-1 receptor agonists: The way forward for the treatment of Parkinson's disease? (vol 11, pg 83, 1999)
Authors: Vermeulen, RJ Drukarch, B Wolters, EC
Citation: Rj. Vermeulen et al., Dopamine D-1 receptor agonists: The way forward for the treatment of Parkinson's disease? (vol 11, pg 83, 1999), CNS DRUGS, 12(1), 1999, pp. 48-48
Dopamine D-1 receptor agonists - The way forward for the treatment of Parkinson's disease?
Authors: Vermeulen, RJ Drukarch, B Wolters, EC Stoof, JC
Citation: Rj. Vermeulen et al., Dopamine D-1 receptor agonists - The way forward for the treatment of Parkinson's disease?, CNS DRUGS, 11(2), 1999, pp. 83-91
Dopaminomimetic psychosis in Parkinson's disease patients - Diagnosis and treatment
Authors: Wolters, EC
Citation: Ec. Wolters, Dopaminomimetic psychosis in Parkinson's disease patients - Diagnosis and treatment, NEUROLOGY, 52(7), 1999, pp. S10-S13
Normal cerebrospinal fluid glutathione concentrations in Parkinson's disease, Alzheimer's disease and multiple system atrophy
Authors: Konings, CH Kuiper, MA Teerlink, T Mulder, C Schltens, P Wolters, EC
Citation: Ch. Konings et al., Normal cerebrospinal fluid glutathione concentrations in Parkinson's disease, Alzheimer's disease and multiple system atrophy, J NEUR SCI, 168(2), 1999, pp. 112-115
Leads for the development of neuroprotective treatment in Parkinson's disease and brain imaging methods for estimating treatment efficacy
Authors: Stoof, JC Winogrodzka, A van Muiswinkel, FL Wolters, EC Voorn, P Groenewegen, HJ Booij, J Drukarch, B
Citation: Jc. Stoof et al., Leads for the development of neuroprotective treatment in Parkinson's disease and brain imaging methods for estimating treatment efficacy, EUR J PHARM, 375(1-3), 1999, pp. 75-86
Identification of axial rigidity during locomotion in Parkinson disease
Authors: Van Emmerik, REA Wagenaar, RC Winogrodzka, A Wolters, EC
Citation: Rea. Van Emmerik et al., Identification of axial rigidity during locomotion in Parkinson disease, ARCH PHYS M, 80(2), 1999, pp. 186-191
Risultati: 1-18 |